Insight into Cardiomyopathy
A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cells of the Cardiovascular System".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 15065
Special Issue Editor
Special Issue Information
Dear Colleagues,
Cardiomyopathy, a pervasive heart muscle disease, has emerged as a leading cause of global mortality, with its incidence doubling over the past century. Cardiomyopathy causes weakness of the heart muscle, which makes it harder for the heart to pump blood effectively. Over time, this can lead to heart failure, arrhythmias (irregular heartbeats), and other complications. The pressing need for effective treatments necessitates a profound understanding of cardiomyopathy at the cellular and molecular levels to discover molecules that can be translated into innovative medicines.
This Special Issue will cover a range of topics, including advancements in in vitro and in vivo models for studying cardiomyopathy, insights into the mechanisms of cardiac remodeling myopathy in animal models, and the identification of key cellular and molecular targets to accelerate the translation of groundbreaking discoveries into tangible medical solutions, ultimately improving outcomes for those affected by this life-threatening condition.
Dr. Sobuj Mia
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heart failure
- ventricular dysfunction
- hypertrophic cardiomyopathy
- dilated cardiomyopathy
- cardiac fibrosis
- cardiac hypertrophy
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
